Top
image credit: vecstock / Freepik

PathAI Expands PathExplore Reach to 14 Cancer Types, Fueling Precision Oncology

January 31, 2024

Category:

Despite advances in cancer treatment, many patients remain unresponsive to available therapies or lack access to potentially life-saving options due to the absence of actionable biomarkers. The TME, a complex ecosystem of cells and tissues surrounding the tumor, holds immense potential for unlocking new therapeutic targets. However, traditional analysis methods struggle to capture the full resolution and spatial intricacies of this intricate landscape.

Read More on HitConsultant